Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer

Tomo Osako; Yoshinori Ito; Masaru Ushijima; Shunji Takahashi; Nahomi Tokudome; Tsutomu Sugihara; Takuji Iwase; Masaaki Matsuura; Kiyohiko Hatake

首页> 外文期刊>Cancer Chemotherapy and Pharmacology >Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer

【24h】

Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer

机译：卡培他滨在转移灶性乳腺癌患者中的疗效预测因素

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose The purpose of the present study is to evaluate what clinical factors affect the efficacy, time to treatment failure (TTF), and overall survival (OS) of oral capecitabine monotherapy in heavily pretreated patients with metastatic breast cancer (MBC).

机译：目的本研究的目的是评估哪些临床因素会影响转移性乳腺癌（MBC）的大量预处理患者中口服卡培他滨单药的疗效，治疗失败时间（TTF）和总体生存期（OS）。

著录项

来源
《Cancer Chemotherapy and Pharmacology》 |2009年第5期|p.865-871|共7页
作者
Tomo Osako; Yoshinori Ito; Masaru Ushijima; Shunji Takahashi; Nahomi Tokudome; Tsutomu Sugihara; Takuji Iwase; Masaaki Matsuura; Kiyohiko Hatake;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer. [J] . Osako T, Ito Y, Ushijima M, Cancer chemotherapy and pharmacology. . 2009,第5期

机译：卡培他滨在接受过大量转移性乳腺癌治疗的患者中疗效的预测因素。
2. Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapies [J] . Sabrina Rossi, Alessandra Cassano, Antonia Strippoli, Drugs In Context . 2017,第2017期

机译：大量接受转移性乳腺癌治疗的患者中eribulin疗效的预后和预测因素：与肿瘤生物学和既往疗法的相关性
3. Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer [J] . FedeleP., MarinoA., OrlandoL., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2012,第1期

机译：低剂量度量化疗用氯己定在重型预处理乳腺癌预处理患者中的疗效和安全性
4. Improving Efficacy of Metastatic Tumor Segmentation to Facilitate Early Prediction of Ovarian Cancer Patients' Response to Chemotherapy [C] . Gopichandh Danala, Yunzhi Wang, Theresa Thai, Biophotonics and immune responses XII . 2017

机译：提高转移性肿瘤分割的功效，以促进卵巢癌患者对化疗的反应的早期预测
5. Blocking immunosuppressive factors and taking advantage of the nutrient supply within the tumor microenvironment: Pathways to achieve improved cancer immunotherapeutic efficacy for patients with metastatic melanoma [D] . Zhang, Ying. 2016

机译：阻断免疫抑制因子并利用肿瘤微环境内的营养供应：途径，以实现转移性黑素瘤患者的改善癌症免疫治疗疗效
6. Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapies [O] . Sabrina Rossi, Alessandra Cassano, Antonia Strippoli, 2017

机译：大量接受转移性乳腺癌治疗的患者中eribulin疗效的预后和预测因素：与肿瘤生物学和既往疗法的相关性
7. Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapies [O] . Sabrina Rossi, Alessandra Cassano, Antonia Strippoli, 2017

机译：受转移性乳腺癌影响的重度预处理患者中艾日布林疗效的预后和预测因素：与肿瘤生物学和既往疗法的相关性

Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer

摘要

著录项

相似文献

相关主题

期刊订阅